Acute myeloid leukemia in 75-year-olds can usually be treated with low-dose chemotherapy. However, since elderly people often have some underlying diseases, such as high blood pressure, diabetes, cardiovascular and cerebrovascular diseases, etc., the specific treatment plan varies from person to person. Acute myeloid leukemia is a common disease. After the onset of the disease, the elderly will experience a series of uncomfortable symptoms, such as anemia, bleeding, and generalized weakness, which will have a certain impact on the quality of life. Regarding this disease, low-dose chemotherapy is the treatment of choice, as well as supportive treatments such as blood transfusion to stop bleeding. Doctors can administer low-dose induction chemotherapy to patients, and choose the appropriate treatment plan in combination with the patient’s physical condition, such as DCAG, etc. The drugs include decitabine, flexibiotics, cytarabine, azulene, azulene, and so on. In addition, supportive therapy is also very important, such as transfusion of suspended red blood cells in case of severe anemia, and transfusion of single harvested platelets in case of thrombocytopenia. In addition, there are options such as clinical trials of new drugs. It is recommended to actively seek medical attention, and treatment should be carried out under the guidance of a physician.